Lacey Pitre

3PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 19, 2023
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer.

Marina Elena Cazzaniga, Foluso Ademuyiwa, Thierry Petit

|Aug 18, 2022
Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results.

Hagen F Kennecke, Chris J O'Callaghan, Jonathan M Loree

|Aug 30, 2019
Is Access to Care Associated With Stage at Presentation and Survival for Melanoma Patients?

Lacey D Pitre, Geordie Linford, Gregory R Pond

Pageof 1